MIZUHO MARKETS AMERICAS LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
MIZUHO MARKETS AMERICAS LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,381,727
+5.9%
402,663
-0.0%
0.54%
-43.4%
Q2 2023$14,528,383
+5.9%
402,783
+12.1%
0.95%
+71.9%
Q1 2023$13,717,199
-12.4%
359,183
+30.5%
0.55%
-40.2%
Q4 2022$15,662,749
+10.4%
275,268
-23.3%
0.92%
+48.4%
Q3 2022$14,184,000358,7180.62%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$256,066,00016.64%
BB BIOTECH AG 8,247,860$149,864,0003.97%
MSD Partners, L.P. 2,245,000$40,792,0003.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 428,633$5,969,0002.84%
First Light Asset Management, LLC 885,523$16,090,0002.60%
SNYDER CAPITAL MANAGEMENT L P 2,387,350$43,378,0001.93%
Sterling Global Strategies LLC 22,000$400,0001.74%
Taylor Wealth Management Partners 221,380$4,022,0001.71%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,228,399$167,680,0001.68%
DOHENY ASSET MANAGEMENT /CA 124,393$2,260,0001.18%
View complete list of HALOZYME THERAPEUTICS INC shareholders